CHICAGO, Sept. 08, 2017 -- LKQ Corporation (Nasdaq:LKQ) today announced that members of its senior management will be presenting at the following investor conferences:
| Raymond James 13th Annual North American Equities Conference | September 12, 2017 | |
| Four Seasons Hotel, London | ||
| Bank of America Merrill Lynch European Credit Conference 2017 | September 13, 2017 | |
| Landmark Hotel, London |
Materials used during the presentations will be posted to the Company's website at www.lkqcorp.com in the Investor Relations section.
About LKQ Corporation
LKQ Corporation (www.lkqcorp.com) is a leading provider of alternative and specialty parts to repair and accessorize automobiles and other vehicles. LKQ has operations in North America, Europe and Taiwan. LKQ offers its customers a broad range of replacement systems, components, equipment and parts to repair and accessorize automobiles, trucks, and recreational and performance vehicles.
Joseph P. Boutross LKQ Corporation Director, Investor Relations (312) 621-2793 [email protected]


Annie Altman Amends Sexual Abuse Lawsuit Against OpenAI CEO Sam Altman
SoftwareONE Posts 22.5% Revenue Surge in 2025 on Crayon Acquisition
Apple Turns 50: From Garage Startup to AI Crossroads
SpaceX Eyes Historic IPO at $1.75 Trillion Valuation
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
McDonald's and Restaurant Brands International Face Headwinds Amid Iran Conflict and Rising Costs
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
Cybersecurity Stocks Tumble After Anthropic's Claude Mythos AI Leak Sparks Market Fears
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Nomura Upgrades PDD Holdings to Buy, Calls Stock Too Cheap to Ignore
Microsoft Eyes $7B Texas Energy Deal to Power AI Data Centers
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
BlackRock CEO Larry Fink Earns $37.7 Million in 2025 Amid Record Growth
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal 



